Abstract:First- and second-hand exposure to smoke or air pollutants is the primary cause of chronic obstructive pulmonary disease (COPD) pathogenesis, where genetic and age-related factors predispose the subject to the initiation and progression of obstructive lung disease. Briefly, airway inflammation, specifically bronchitis, initiates the lung disease, leading to difficulty in breathing (dyspnea) and coughing as initial symptoms, followed by air trapping and inhibition of the flow of air into the lungs due to damage to the alveoli (emphysema). In addition, mucus obstruction and impaired lung clearance mechanisms lead to recurring acute exacerbations causing progressive decline in lung function, eventually requiring lung transplant and other lifesaving interventions to prevent mortality. It is noteworthy that COPD is much more common in the population than currently diagnosed, as only 16 million adult Americans were reported to be diagnosed with COPD as of 2018, although an additional 14 million American adults were estimated to be suffering from COPD but undiagnosed by the current standard of care (SOC) diagnostic, namely the spirometry-based pulmonary function test (PFT). Thus, the main issue driving the adverse disease outcome and significant mortality for COPD is lack of timely diagnosis in the early stages of the disease. The current treatment regime for COPD emphysema is most effective when implemented early, on COPD onset, where alleviating symptoms and exacerbations with timely intervention(s) can prevent steep lung function decline(s) and disease progression to severe emphysema. Therefore, the key to efficiently combatting COPD relies on early detection. Thus, it is important to detect early regional pulmonary function and structural changes to monitor modest disease progression for implementing timely interventions and effectively eliminating emphysema progression. Currently, COPD diagnosis involves using techniques such as COPD screening questionnaires, PFT, arterial blood gas analysis, and/or lung imaging, but these modalities are limited in their capability for early diagnosis and real-time disease monitoring of regional lung function changes. Hence, promising emerging techniques, such as X-ray phase contrast, photoacoustic tomography, ultrasound computed tomography, electrical impedance tomography, the forced oscillation technique, and the impulse oscillometry system powered by robust artificial intelligence and machine learning analysis capability are emerging as novel solutions for early detection and real time monitoring of COPD progression for timely intervention. We discuss here the scope, risks, and limitations of current SOC and emerging COPD diagnostics, with perspective on novel diagnostics providing real time regional lung function monitoring, and predicting exacerbation and/or disease onset for prognosis-based timely intervention(s) to limit COPD-emphysema progression.

[Advances in chest imaging in early chronic obstructive pulmonary disease].

Probing Changes in Lung Physiology in COPD Using CT, Perfusion MRI, and Hyperpolarized Xenon-129 MRI

Progress in the imaging of COPD: quantitative and functional evaluation

Lung imaging in COPD and asthma

Diagnostic imaging in COPD

State of the art review | Advances in COPD imaging using CT and MRI: Linkage with lung physiology and clinical outcomes

Computed tomography‐based artificial intelligence in lung disease—Chronic obstructive pulmonary disease

Early Diagnosis and Real-Time Monitoring of Regional Lung Function Changes to Prevent Chronic Obstructive Pulmonary Disease Progression to Severe Emphysema

ROLE OF CHEST COMPUTED TOMOGRAPHY IN EVALUATION AND MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

DIAGNOSTIC IMAGING OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A TEN YEARS SYSTEMATIC REVIEW

Computed tomography-identified phenotypes of small airway obstructions in chronic obstructive pulmonary disease

Detection methods and research progress of small airways in chronic obstructive pulmonary disease

Artificial intelligence in COPD CT images: identification, staging, and quantitation

Early Detection of Cardiac Dysfunction in Stable Chronic Obstructive Pulmonary Disease Patients

Advancements in automated classification of chronic obstructive pulmonary disease based on computed tomography imaging features through deep learning approaches

A Preliminary Study on the Relationship Between High-Resolution Computed Tomography and Pulmonary Function in People at Risk of Developing Chronic Obstructive Pulmonary Disease

Twenty Years of Changes in the Definition of Early Chronic Obstructive Pulmonary Disease

Early Chronic Obstructive Pulmonary Disease: A New Perspective

Exploration of Multi-Aspect Development of Chronic Obstructive Pulmonary Disease Pathogenesis, Diagnosis, and Treatment Management

Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation

Quantitative Evaluation of Chronic Obstructive Pulmonary Disease and Risk Prediction of Acute Exacerbation by High-Resolution Computed Tomography